MYLAN G1 (Glipizide 5 mg)

Pill imprint MYLAN G1 has been identified as Glipizide 5 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MYLAN G1

Glipizide 5 mg MYLAN G1
Glipizide 5 mg MYLAN G1  Front
Glipizide 5 mg MYLAN G1  Back
Glipizide 5 mg MYLAN G1
Glipizide
Imprint:
MYLAN G1
Strength:
5 mg
Color:
White
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-1105
Inactive Ingredients:
silicon dioxide
lactose anhydrous
microcrystalline cellulose
corn starch
stearic acid
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0810 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)